Goldman Sachs Boosts Price Target On Cepheid (CPHD) to $46

Goldman Sachs lifted its price target on Cepheid (NASDAQ: CPHD) from $42 to $46 following strong Q4 results.

They noted that the revenue beat represents 36% year-over-year growth and was enabled by the company's biggest instrumentation quarter thus far.

"The 4Q results reinforce CPHD’s status as the highest growth name in our coverage universe, justifying a continued valuation premium vs. peers in our view," the firm comments.

For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.

Shares of Cepheid are up 20 percent today to $41.31.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'